Current Advances of Artificial Pancreas Systems: A Comprehensive Review of the Clinical Evidence
Since Banting and Best isolated insulin in the 1920s, dramatic progress has been made in the treatment of type 1 diabetes mellitus (T1DM). However, dose titration and timely injection to maintain optimal glycemic control are often challenging for T1DM patients and their families because they require...
Guardado en:
Autores principales: | Sun Joon Moon, Inha Jung, Cheol-Young Park |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Korean Diabetes Association
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5d7d1bb4460740ed8982101ff13b0d9e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
De la bomba de insulina y el monitoreo continuo de glucosa al páncreas artificial
por: Apablaza,Pamela, et al.
Publicado: (2017) -
Evolución de los sistemas de infusión de insulina: el camino al páncreas artificial
por: Raquel N. Faradji-Hazán, et al.
Publicado: (2021) -
Implications of remote monitoring Technology in Optimizing Traditional Self-Monitoring of blood glucose in adults with T2DM in primary care
por: Alex R. Montero, et al.
Publicado: (2021) -
Evaluating Glycemic Control During Basalin or Lantus Administration in Adults With Controlled Type 2 Diabetes Mellitus Using Continuous Glucose Monitoring
por: Huiying Wang, et al.
Publicado: (2021) -
A quality improvement initiative to successfully reduce the frequency of hypoglycemia during treatment of hyperglycemic crises at an academic safety-net hospital: Insights and results
por: Katherine L. Modzelewski, et al.
Publicado: (2021)